Maintenance is scheduled between 9pm - 9am AEST, Thursday 26 to Friday 27 March 2026 and the site may be unavailable or slow during this time.
This item is authorised by the following title:
To include a retrospective amendment made by the Therapeutic Goods (Excluded Goods) Amendment Determination (No. 2) 2024
Therapeutic Goods (Excluded Goods) Amendment (Sunscreen) Determination 2024 (F2024L00657)
Therapeutic Goods (Excluded Goods) Amendment Determination 2024 (F2024L00692)
Therapeutic Goods (Excluded Goods) Amendment (Vaping) Determination 2024 (F2024L00843)
Therapeutic Goods (Excluded Goods) Amendment Determination (No. 2) 2024 (F2024L00985)
Therapeutic Goods (Excluded Goods) Amendment (Vaping) Determination 2023 (F2023L01684)
Mitochondrial Donation Law Reform (Maeve’s Law) Act 2022 (Act No. 26, 2022 | C2022A00026)
Therapeutic Goods (Excluded Goods) Amendment (Personalised Medical Devices) Determination 2021 (F2021L01161)
Therapeutic Goods (Excluded Goods) Amendment (Borderline Products—COVID-19) Determination 2021 (F2021L01049)
Therapeutic Goods (Excluded Goods) Amendment (Software-based Products) Determination 2021 (F2021L00047)
Therapeutic Goods (Excluded Goods) Amendment (Vaping Devices) Determination 2021 (F2021L00112)
Therapeutic Goods Amendment (Excluded Goods) Determination (No. 1) 2020 (F2020L00464)
Therapeutic Goods Amendment (Excluded Goods) Determination (No. 2) 2019 (F2019L00985)
View Explanatory Statement/s
